Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Services Revenue — Note 6 by Year
Services Revenue — Note 6 ($M)
Thermo Fisher Scientific Services Revenue — Note 6: $18,592M in FY2025, up 4.2% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
“|| Services | 18,592 | 17,845 | 17,614”
Source: SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Revenue from clinical research services (PPD), contract pharmaceutical manufacturing (Patheon), and instrument technical services. Q4 = FY − 9M.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Services Revenue — Note 6 ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18,592 | +4.2% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 17,845 | +1.3% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 17,614 | +7.6% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 16,367 | +84.9% | SEC Form 10-K (10k_2024, filed 2025-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 8,850 | +28.0% | SEC Form 10-K (10k_2023, filed 2024-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 6,912 | +14.3% | SEC Form 10-K (10k_2022, filed 2023-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 6,046 | +10.1% | SEC Form 10-K (10k_2021, filed 2022-02-24) ↗ |
| FY2018 | Dec 31, 2018 | 5,490 | – | SEC Form 10-K (10k_2020, filed 2021-02-25) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Services Revenue — Note 6 ($M), annual FY2018–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-type-services
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.